• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Jan / 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Dec    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing

Tedros Adhanom Ghebreyesus, Director-General

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera

Adham Jurdi

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

OncoCalendar

12 events found.

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
Today
  • March 2026

  • Sun 15
    Cancer Immunotherapy
    Mar 15 - Mar 18

    Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations

    Fairmont Le Château Frontenac 1 Rue des Carrières, Québec, Québec, Canada

    The Keystone Symposia conference, "Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations," will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada. This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, […]

  • Mon 16
    ESMO TAT
    Mar 16 - Mar 18

    ESMO Targeted Anticancer Therapies Congress 2026

    Palais des Congrès de Paris 2 Pl de la Pte Maillot, Paris, Île-de-France, France

    The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […]

  • Tue 17
    Tumour Ecosystem
    Mar 17 - Mar 19

    The Tumour Ecosystem: From Mechanisms to Novel Therapeutics

    Centro Congressi Giovanni XXIII Viale Papa Giovanni XXIII, 106, Bergamo, Lombardy, Italy

    The EACR conference on The Tumour Ecosystem: From Mechanisms to Novel Therapeutics will be held from 17 to 19 March 2026 in Bergamo, Italy. Organized by the European Association for Cancer Research (EACR), the event's venue is the Centro Congressi Giovanni XXIII. The conference will focus on the latest research in the tumor microenvironment, covering how cancer […]

  • Tue 17
    From Protocol to Publication
    Mar 17 - Mar 19

    From Protocol to Publication: A Practical Course in Clinical Research

    The "From Protocol to Publication: A Practical Course in Clinical Research" is an exclusive, in-person training event organized by the European School of Oncology (ESO). Scheduled for 17 to 18 March 2026 in Milan, Italy, this advanced, two-day workshop is reserved only for the ten members of the ESO College who achieve the highest scores […]

  • Tue 17
    TROG
    Mar 17 - Mar 20

    TROG Annual Scientific Meeting 2026

    Pullman Melbourne Albert Park 65 Queens Rd, Albert Park VIC 3004, Australia, Melbourne, Victoria, Australia

    The 38th TROG Annual Scientific Meeting (ASM), hosted by the Trans-Tasman Radiation Oncology Group (TROG) Cancer Research, will be held in Melbourne from March 17 to 20, 2026. The conference theme is "Driving Intelligent Trials," which focuses on using smarter designs, AI-driven insights, and stronger trial systems to achieve better research outcomes in radiation oncology. […]

  • Thu 19
    The ICHNO 2026
    Mar 19 • 8:00 AM - Mar 21 • 5:00 PM

    The ICHNO 2026

    Fibes - Conference and Exhibition Ave. Alcalde Luis Uruñuela, 1, Seville, Spain

    The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […]

  • Wed 25
    ANZGOG 2026
    Mar 25 - Mar 27

    ANZGOG 2026 Annual Scientific Meeting

    Gold Coast Convention and Exhibition Centre 2684 - 2690 Gold Coast Highway, Broadbeach, Queensland, Australia

    The ANZGOG 2026 Annual Scientific Meeting is a flagship event of the Australian New Zealand Gynaecological Oncology Group (ANZGOG). The 2026 ASM, themed "On the Edge: Translating Innovation into Action," is scheduled for March 25–27, 2026, on the Gold Coast, Queensland. It serves as a dynamic forum for national and international experts - including gynaecological […]

  • Wed 25
    ESMO Guidelines
    Mar 25

    ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026

    Virtual Event

    The ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25, 2026, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. Chaired by Ana Oaknin, the webinar features a multidisciplinary panel of experts who discuss the diagnosis, staging, […]

  • Wed 25
    SITC Spring Scientific
    Mar 25 - Mar 27

    2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules

    El Conquistador Tucson, A Hilton Resort 10000 N Oracle Rd, Tucson, AZ, United States

    The 2026 SITC Spring Scientific: Enhancing Cellular Therapies with Next-generation IO Molecules will be held from March 25–27, 2026, in a hybrid format with options to attend in Tucson, Arizona, or virtually. Organized by the Society for Immunotherapy of Cancer (SITC), the program will bring together experts in cell therapy, drug development, and immuno-oncology to […]

  • Wed 25
    ELCC 2026
    Mar 25 • 8:00 AM - Mar 28 • 5:00 PM

    The European Lung Cancer Congress (ELCC 2026)

    Bella Center Center Boulevard 5, Copenhagen, Denmark

    The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]

  • Thu 26
    Stereotactic Radiotherapy
    Mar 26 - Mar 28

    Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions

    Ospedale Isola Tiberina - Gemelli Isola Via di Ponte Quattro Capi, 39, Rome, Rome Metropolitan City, Italy

    The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome, Italy, from March 26–28, 2026. `Directed by Maximilian Niyazi, this course is designed to allow radiation oncologists, medical physicists, radiation therapists, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating […]

  • Thu 26
    Japanese Society of Medical Oncology
    Mar 26 - Mar 28

    2026 Japanese Society of Medical Oncology Annual Meeting

    PACIFICO Yokohama 1 Chome-1-1 Minatomirai, Nishi Ward, Yokohama, Kanagawa, Japan

    The 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO2026) will take place from March 26–28, 2026, at PACIFICO Yokohama North and Exhibition Hall D in Yokohama, Japan. Centered on the theme “Medical Oncologists for Cancer Patients,” this year’s meeting marks the 20th anniversary of JSMO’s board certification program and offers a timely […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer prostate cancer AACR clinical trials FDA UICC Dana-Farber Cancer Institute European Cancer Organisation American Cancer Society SIOP NCI chemotherapy Myeloma National Cancer Institute Robert Orlowski American Society of Clinical Oncology Vivek Subbiah healthcare Myeloma Paper of the Day Paolo Tarantino AI IASLC Pancreatic Cancer ASCO25 radiation oncology WHO multiple myeloma cervical cancer Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}